AstraZeneca Logo PNG
The “Astrazeneca” logo combines clarity and elegance. It demonstrates the progress of scientific thought and the excellent results of the tandem of two pharmaceutical giants. The emblem is like a golden sign, symbolizing universal benefit.
AstraZeneca was formed from two older companies, Sweden’s Astra AB and Britain’s Zeneca Group. Astra was founded in Södertälje in 1913 by about 400 doctors and pharmacists, including Adolf Rising, to reduce Sweden’s dependence on German and Swiss medicines. Under Börje Gabrielsson, CEO from 1927 to 1957, Astra became a major Swedish drugmaker. In 1948, it launched penicillin and the anesthetic xylocaine, later funding research behind Losec, also known as Prilosec, and Aptin.
Zeneca came from Imperial Chemical Industries, or ICI, founded in Britain in 1926. Its pharmaceutical division included Sir James Black, who won the 1988 Nobel Prize for his work on beta-blockers. In 1993, ICI spun off its pharmaceutical and agrochemical businesses as Zeneca, a new public company. Zeneca focused strongly on oncology, with products such as Casodex, Nolvadex, and Zoladex, and bought Salick Health Care in stages between 1994 and 1997.
In December 1998, Astra and Zeneca announced a merger valued at about $35 billion, with the wider combined deal estimated at $67 billion. The merger was completed on April 6, 1999, creating AstraZeneca PLC. Zeneca shareholders received 53.5% of the new company, Astra shareholders 46.5%, and Tom McKillop became the first CEO.
After 1999, AstraZeneca expanded through acquisitions, including Cambridge Antibody Technology in 2006; MedImmune for about $15.2 billion in 2007; Novexel in 2009; Ardea Biosciences in 2012; Amylin Pharmaceuticals with Bristol-Myers Squibb; and Alexion Pharmaceuticals for about $39 billion in 2021. Its main competitors included GlaxoSmithKline and Pfizer, whose $118 billion takeover attempt in 2014 was rejected.
Meaning and History
The company’s history begins with the appearance of Astra AB in 1913. Imperial Chemical Industries, the second participant, appeared in 1926. Their paths ran parallel until 1999, when the two pharmaceutical giants merged into AstraZeneca.
The emblem plays on the theme of unification, highlighting the benefits of a joint venture.
What is AstraZeneca?
A medical conglomerate with a turnover of $ 37.5 billion. It ranks tenth in the world in drug sales. The company has 24 unique prescription drug formulations to its credit. It has two headquarters: one in the United Kingdom and one in Sweden.
1999 – today
The visual symbol was created by the world-renowned English branding agency Interbrand. Thanks to its 50-year experience in this field, the design firm created a unique and memorable logo that the company has used for over two decades.
The emblem consists of text and an image.
The name is written in thin dark-blue letters, highlighting the company’s past. The two capital letters draw attention to the two companies that merged to create the pharmaceutical conglomerate. Each is given a place in the name, depending on seniority.
Sweden’s largest company, Astra AB, with a nearly century-long history, justifiably occupies the top spot in the name. The joint venture led to advances in analgesia and in the treatment of heart disease, blood vessel disorders, gastrointestinal tract disorders, and respiratory system disorders.
Zeneca was formed just six years before its merger with Astra AB, the pharmaceutical division of a large British chemical industry holding company. Zeneca’s research portfolio was significantly smaller, with only a few oncology drugs and Tenormin, a drug that normalizes heart muscle function. That is why its name ranks second in the joint brand.
The thin, serif-free letters indicate a measured scientific approach, research, adherence to protocols, and international standards. The conglomerate’s drugs are tested, safe, and highly specialized.
The joint symbol consists of the first two letters of the names, raised above the surface and forming an intricate network of lines and loops.
The merger’s contours resemble the following:
- a microscope pointing to laboratory research;
- an hourglass, representing the infinity of time, continuous development, and improvement of medicine;
- a vessel of the Greek goddess Hygieia: a symbol of healing in the form of a bowl with a snake wrapped around it.
The image is executed in gold, demonstrating the success of their joint work and a significant contribution to the global pharmaceutical industry. Thanks to scientific research, AstraZeneca introduced the world to Losec, an omeprazole-based drug that relieves symptoms of ulcers and gastritis. After its appearance in 1996, it became the best-selling drug worldwide. Other well-known drugs include metoprolol and propranolol for the heart, Pulmicort for asthma, asthmatic bronchitis, and laryngospasm. Tamoxifen is the leading drug for breast cancer treatment.
Font and Colors
The logo features two shades: dark blue and gold.
The dark blue text color emphasizes the company’s scientific orientation, research activities, and a rich database of proven results. The shade guarantees reliability, solid age, and concern for patients’ health.
Gold represents profitability and leadership. The color indicates achievements and victories. It demonstrates increased profitability and weight in the global business landscape through the tandem, symbolizing an indestructible union and unification for centuries.
The font of the inscription is similar to Seibi Ai Bold.